CTOs on the Move

Institut National de Sante Publique du Quebec

www.inspq.qc.ca

 
Our goal is to advance knowledge and propose crosssectoral strategies and endeavours that will improve the health and well-being of Québecers. The Institut national de santé publique du Québec (INSPQ) was created in 1998 following the adoption of its act of incorporation (RSQ, chapter I-13.1.1). Its experts come from fields as distinct as applied science, health sciences, social sciences, and humanities and work with the health and social services network to develop and pool public health knowledge and skills.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.inspq.qc.ca
  • 945, av Wolfe
    Quebec City, QC CAN G1V 5B3
  • Phone: 418.650.5115

Executives

Name Title Contact Details

Similar Companies

HealthLynked

HealthLynked (OTCQB: HLYK) provides a solution for both patient members and providers to improve healthcare by efficiently exchanging medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take control of their medical data. Members can enter their medications, allergies, past surgeries, and personal health records into one convenient online and secure location. Participating healthcare providers can connect with their current and future patients through the HealthLynked Network. Providers also get the benefit of using HealthLynked marketing tools to communicate with their active and inactive patients to improve patient retention, access accurate patient information, and provide efficient online scheduling.

Broadmoor

Broadmoor is a Fort Pierce, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PHNS

PHNS provides comprehensive information technology and business process services to hospitals, healthcare providers and other businesses across the United States.

Trenton Orthopaedic Group, PA

Trenton Orthopaedic Group, PA is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.